• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    S.M.I.L.E. Healthcare Pathway Program Announces Strategic Expansion With Leading Dental Industry Partners

    6/10/24 7:00:00 AM ET
    $HSIC
    Medical Specialities
    Health Care
    Get the next $HSIC alert in real time by email

    The S.M.I.L.E. (Student Mentoring with Immersive Learning and Enrichment) Healthcare Pathway Program, a leader in advancing oral health equity, is pleased to announce the addition of several prominent organizations as supporters of its mission to build a more inclusive healthcare workforce by recruiting students from historically underrepresented backgrounds to enter the dental profession.

    The founding partners of S.M.I.L.E. – Henry Schein, Inc. (NASDAQ:HSIC), the National Dental Association (NDA), and the Schattner Foundation – are delighted to welcome the following organizations as supporting partners for the 2024 S.M.I.L.E. Program: the Hispanic Dental Association; the Society of American Indian Dentists; Meharry Medical College School of Dentistry; A.T. Still University's Arizona School of Dentistry & Oral Health; and, A.T. Still University's Missouri School of Dentistry & Oral Health. Working together, these partners seek to advance the core mission of cultivating a diverse and talented next-generation of African-American, Hispanic, and American Indian dental professionals, ultimately ensuring a more equitable dental landscape.

    The S.M.I.L.E. Program engages rising 9th and 10th-grade students by providing an introduction to the many exciting career opportunities available within the oral health profession. Through a week-long immersive experience, participants gain exposure to the diverse roles within dental teams, including assisting, hygiene, and dentistry, along with insights into various practice models and industry positions.

    Program highlights include:

    • Mentorship: Dedicated dental professionals provide valuable guidance and share their expertise with students.
    • Hands-On Learning: Participants engage in real-world procedures, developing practical skills crucial for future dental careers.
    • Career Pathway Exposure: Students explore a wide range of dental career options, facilitating informed choices about their professional path.
    • Collaboration & Networking: Students will meet fellow rising 9th and 10th-graders from around the country, developing social skills and building relationships for a lifetime.
    • Capstone Project: The program culminates in a capstone project, allowing students to showcase their learnings through a tangible presentation.

    2024 Program Details

    The 2024 S.M.I.L.E. Program will take place from July 7 to 12 at Meharry Medical College School of Dentistry in Nashville, Tennessee. To learn more about the Program and view highlights from 2023 participants, please watch this video.

    For more information about the Program, please visit the official S.M.I.L.E. Program website: https://ndaonline.org/smile-program.

    PARTNER TESTIMONIALS

    Cherae Farmer-Dixon, DDS, MSPH, MBA, FACD, FICD

    Dean, Meharry School of Dentistry

    "Joining forces with Meharry School of Dentistry through our partnership with Henry Schein signifies a commitment to revolutionizing oral healthcare access. This collaboration is not just about dental care; it's about empowering communities, bridging gaps in healthcare equity, and fostering a brighter, healthier future for all. Together, we aim to redefine the standards of care, break down barriers, and inspire a new generation of dental professionals dedicated to serving the underserved.

    Furthermore, it's noteworthy that 27% of the currently practicing African American dentists in the U.S. are Meharry Medical College graduates. Programs such as this partnership not only highlight our commitment to diversity in the field but also serve as a beacon of inspiration for the next generation of individuals, encouraging them to consider dentistry as a rewarding and impactful career path. Through our joint efforts, we aspire to increase representation, improve access to quality care, and ultimately, transform lives."

    Dr. Nicole Cheek, 100th President of the National Dental Association

    "Being a part of the S.M.I.L.E. Pathway Program is about transforming the lives of students and achieving a future where they can thrive in dentistry and oral health, regardless of their backgrounds. In a world where access to opportunities is unequal, programs like S.M.I.L.E. are needed to bridge the gap and empower individuals to reach their full potential. Through mentorship, education, and support, S.M.I.L.E. aims to cultivate leaders who will make positive impacts in oral health, their communities and beyond."

    Maria S. Gomez, Board Member, Schattner Foundation

    "The Schattner Foundation is committed to supporting the next generation of dental practitioners who come from underrepresented communities throughout the country. Our intention in participating with our advice and resources is to help support a strong and lasting program that over time will deliver on the promise of recruiting high school students into dental careers who will practice in neighborhoods where oral health is most needed."

    Pam Richter, Director, Corporate Affairs and Inclusion, Henry Schein and Co-Lead, S.M.I.L.E. Program Director

    "Henry Schein, alongside our distinguished partners, is excited to build on the S.M.I.L.E. program's success. This initiative empowers diverse students to pursue healthcare careers through mentorship and immersive learning, aiming to improve health equity in underserved communities. With the additional support from our partners, we will engage 40 students this year, igniting their passion for healthcare and creating lasting change."

    Christina Meiners D.D.S, F.I.C.D, Hispanic Dental Association Past President, Interim Executive Director

    "The Hispanic Dental Association is excited to collaborate in this effort to help increase access to and awareness of careers in dentistry and healthcare. We understand the power a diverse healthcare provider has on improving the health of our communities and the influence a program like this has on creating opportunities for our youth. With this partnership we hope to create a network of support for students who want to learn more about this amazing profession."

    Ruth Wauqua Bol DDS MPD ICD, (Comanche), Society of American Indian Dentists Past President, 2011-2013

    "The Society of American Indian Dentists is honored to collaborate on the S.M.I.L.E. oral health pathway summer enrichment program. Our American Indian and Alaska Native population continues to experience the highest rates of unmet dental need in the country. This unique opportunity allows us to introduce American Indian and Alaska Native high school students to the field of dentistry. It is our sincerest hope that this experience will help smooth the pathway to dental school so these students can one day provide care in our communities."

    Clinton Normore, MBA, Vice President, Diversity & Inclusion, MOSDOH & ASDOH Instructor, A.T. Still University

    "ATSU has a history of providing access and opportunity for marginalized populations. Partnerships like this are essential for improving workforce diversity and improving health outcomes. We aim for this partnership to engage, energize, and nurture young minds towards a healthcare career."

    View source version on businesswire.com: https://www.businesswire.com/news/home/20240604842697/en/

    Get the next $HSIC alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $HSIC

    DatePrice TargetRatingAnalyst
    2/23/2026$100.00Neutral → Outperform
    Robert W. Baird
    12/9/2025$86.00Overweight
    Barclays
    8/26/2025$83.00In-line → Outperform
    Evercore ISI
    7/25/2025$75.00Buy → Hold
    Stifel
    7/14/2025$72.00Outperform → Neutral
    Robert W. Baird
    2/14/2025$80.00Equal Weight
    Wells Fargo
    1/6/2025$69.00 → $84.00Underperform → Buy
    BofA Securities
    12/4/2024$75.00Neutral
    Mizuho
    More analyst ratings

    $HSIC
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Henry Schein upgraded by Robert W. Baird with a new price target

    Robert W. Baird upgraded Henry Schein from Neutral to Outperform and set a new price target of $100.00

    2/23/26 8:29:17 AM ET
    $HSIC
    Medical Specialities
    Health Care

    Barclays initiated coverage on Henry Schein with a new price target

    Barclays initiated coverage of Henry Schein with a rating of Overweight and set a new price target of $86.00

    12/9/25 8:50:15 AM ET
    $HSIC
    Medical Specialities
    Health Care

    Henry Schein upgraded by Evercore ISI with a new price target

    Evercore ISI upgraded Henry Schein from In-line to Outperform and set a new price target of $83.00

    8/26/25 8:13:41 AM ET
    $HSIC
    Medical Specialities
    Health Care

    $HSIC
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Popeck Thomas C

    4 - HENRY SCHEIN INC (0001000228) (Issuer)

    3/20/26 4:07:39 PM ET
    $HSIC
    Medical Specialities
    Health Care

    SVP & Chief Financial Officer South Ronald N. covered exercise/tax liability with 5,216 shares, decreasing direct ownership by 6% to 88,930 units (SEC Form 4)

    4 - HENRY SCHEIN INC (0001000228) (Issuer)

    3/17/26 4:17:50 PM ET
    $HSIC
    Medical Specialities
    Health Care

    SVP, Chief Human Res. Officer Sheehy Christine Zayac covered exercise/tax liability with 463 shares, decreasing direct ownership by 2% to 18,454 units (SEC Form 4)

    4 - HENRY SCHEIN INC (0001000228) (Issuer)

    3/17/26 4:15:54 PM ET
    $HSIC
    Medical Specialities
    Health Care

    $HSIC
    SEC Filings

    View All

    Amendment: SEC Form SCHEDULE 13G/A filed by Henry Schein Inc.

    SCHEDULE 13G/A - HENRY SCHEIN INC (0001000228) (Subject)

    3/27/26 9:30:37 AM ET
    $HSIC
    Medical Specialities
    Health Care

    SEC Form 144 filed by Henry Schein Inc.

    144 - HENRY SCHEIN INC (0001000228) (Subject)

    3/19/26 12:30:49 PM ET
    $HSIC
    Medical Specialities
    Health Care

    SEC Form 10-K filed by Henry Schein Inc.

    10-K - HENRY SCHEIN INC (0001000228) (Filer)

    2/24/26 4:42:20 PM ET
    $HSIC
    Medical Specialities
    Health Care

    $HSIC
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Henry Schein One Unveils the Next Era of Dentrix Ascend for DSOs and Growth-Focused Practices

    New Packages Accelerate Revenue Through an Integrated, Agentic Platform Henry Schein One, the market leader in dental practice management systems, today unveiled the next era of Dentrix Ascend—introducing three new packages built on a fully integrated, agentic platform architecture designed to help practices and Dental Service Organizations (DSOs) increase revenue and accelerate growth. The new offering strengthens Dentrix Ascend's position as the platform of choice for modern dental organizations while advancing Henry Schein One's strategy to unify practice management, clinical workflows, imaging, and revenue cycle management within a single intelligent platform. Momentum behind Dent

    3/10/26 6:30:00 AM ET
    $HSIC
    Medical Specialities
    Health Care

    Henry Schein to Participate in Upcoming Investor Conferences in March

    Henry Schein, Inc., the world's largest provider of health care solutions to office-based dental and medical practitioners, announced today that the Company will present at the following conferences in March: Leerink's Global Healthcare Conference at the W South Beach hotel, Miami, on March 9, at 10:00 a.m. EST. Barclays 28th Annual Global Healthcare Conference at the Loews Miami Beach hotel, Miami, on March 10, at 10:30 a.m. EST. Henry Schein's presentations can be heard via live webcast by visiting www.henryschein.com/IRwebcasts. Replays will be available on the Henry Schein website following the presentations. About Henry Schein, Inc. Henry Schein, Inc. (NASDAQ:HSIC) is a so

    3/3/26 6:30:00 AM ET
    $HSIC
    Medical Specialities
    Health Care

    Biomerica Reports Real-World Data: Nearly 60% of IBS Patients Achieved Clinically Meaningful Pain Reduction and 68% Achieved Bloating Reduction with the inFoods® IBS Therapy

    Key Highlights Responder Analysis: 59.4% of patients achieved ≥30% reduction in abdominal pain; 68.1% achieved ≥30% reduction in bloating—using the FDA-recognized responder endpoint consistent with the Company's peer-reviewed randomized controlled trial.CMS Payment Rate: $300 national Medicare payment rate established, effective January 1, 2026.Physician Perspective: New interview with Gastroenterologist Dr. Dak Patel about inFoods IBS in clinical use now available at https://investors.biomerica.com/events-and-presentations/default.aspx IRVINE, Calif., Feb. 26, 2026 (GLOBE NEWSWIRE) -- Biomerica, Inc. (NASDAQ:BMRA), an innovator in diagnostic-guided therapy, today announced respo

    2/26/26 8:19:00 AM ET
    $BMRA
    $HSIC
    Biotechnology: In Vitro & In Vivo Diagnostic Substances
    Health Care
    Medical Specialities

    $HSIC
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Daniel William K bought $670,800 worth of shares (10,000 units at $67.08) (SEC Form 4)

    4 - HENRY SCHEIN INC (0001000228) (Issuer)

    8/11/25 4:26:33 PM ET
    $HSIC
    Medical Specialities
    Health Care

    $HSIC
    Financials

    Live finance-specific insights

    View All

    Henry Schein Reports Fourth Quarter and Full Year 2025 Financial Results and Introduces 2026 Financial Guidance

    Q4 2025 GAAP diluted EPS of $0.85, compared to $0.74 GAAP diluted EPS in Q4 2024 Q4 2025 non-GAAP diluted EPS of $1.34, compared to $1.19 non-GAAP diluted EPS in Q4 2024 2026 non-GAAP diluted EPS expected to be in the range of $5.23 to $5.37, with total sales growth expected to be 3-5% Henry Schein, Inc. (NASDAQ:HSIC), the world's largest provider of health care solutions to office-based dental and medical practitioners, today reported financial results for the fourth quarter ended December 27, 2025. "Our fourth-quarter sales reflect continuing momentum resulting in the highest sales growth in 15 quarters. We are pleased with the sales results across all our businesses, particul

    2/24/26 6:00:00 AM ET
    $HSIC
    Medical Specialities
    Health Care

    Henry Schein to Webcast Fourth Quarter 2025 Conference Call on Tuesday, February 24, 2026, at 8:00 A.M. ET

    Henry Schein, Inc. (NASDAQ:HSIC), the world's largest provider of healthcare solutions to office-based dental and medical practitioners, announced today that it will release its fourth quarter 2025 financial results before the stock market opens on Tuesday, February 24, 2026, and will provide a live webcast of its earnings conference call on the same day beginning at 8:00 a.m. Eastern time. Speakers on the call will include Stanley M. Bergman, Chairman of the Board and Chief Executive Officer, and Ronald N. South, Senior Vice President and Chief Financial Officer. Investors can access the call by visiting https://investor.henryschein.com/webcasts. A replay will be available on the Henry S

    1/22/26 6:30:00 AM ET
    $HSIC
    Medical Specialities
    Health Care

    Henry Schein Reports Record Third Quarter 2025 Financial Results and Raises Full Year Non-GAAP EPS Guidance

    Q3 2025 GAAP diluted EPS of $0.84, compared to $0.78 GAAP diluted EPS in Q3 2024, and Q3 2025 non-GAAP diluted EPS of $1.38, compared to $1.22 non-GAAP diluted EPS in Q3 2024 Raises 2025 guidance for non-GAAP diluted EPS to $4.88 to $4.96 and sales growth to 3-4% to reflect third quarter results Announces value creation initiatives expected to deliver over $200 million of operating income improvement over the next few years Agreement reached to provide KKR the right to increase its HSIC stock ownership up to 19.9% Henry Schein, Inc. (NASDAQ:HSIC), the world's largest provider of health care solutions to office-based dental and medical practitioners, today reported financial results

    11/4/25 6:00:00 AM ET
    $HSIC
    Medical Specialities
    Health Care

    $HSIC
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Henry Schein Inc.

    SC 13G/A - HENRY SCHEIN INC (0001000228) (Subject)

    11/13/24 3:30:01 PM ET
    $HSIC
    Medical Specialities
    Health Care

    SEC Form SC 13G filed by Henry Schein Inc.

    SC 13G - HENRY SCHEIN INC (0001000228) (Subject)

    11/12/24 9:32:27 AM ET
    $HSIC
    Medical Specialities
    Health Care

    SEC Form SC 13G/A filed by Henry Schein Inc. (Amendment)

    SC 13G/A - HENRY SCHEIN INC (0001000228) (Subject)

    2/14/24 11:18:57 AM ET
    $HSIC
    Medical Specialities
    Health Care

    $HSIC
    Leadership Updates

    Live Leadership Updates

    View All

    Henry Schein Enters Exclusive Distribution Agreement for CytoChip's CLIA-Waived Hematology Analyzer

    Partnership Expands Access to FDA-Cleared CitoCBC® System Across the U.S. Henry Schein, Inc. (NASDAQ:HSIC) has entered into a new exclusive distribution agreement with CytoChip Inc. for its flagship product, the CitoCBC® system, a U.S. Food and Drug Administration (FDA) 510(k)-cleared device. Available now to Henry Schein customers in the United States, the CitoCBC system is the first cartridge-based Complete Blood Count (CBC) system to receive a CLIA Waiver, helping expand access to accurate, lab-quality testing at the point of care. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260115495488/en/CLIA Waived CitoCBC System Des

    1/15/26 10:00:00 AM ET
    $HSIC
    Medical Specialities
    Health Care

    Henry Schein Names Frederick M. Lowery as Chief Executive Officer

    Industry veteran brings more than 20 years of healthcare distribution experience and operational excellence Henry Schein, Inc. (NASDAQ:HSIC), the world's largest provider of healthcare solutions to office-based dental and medical professionals, today announced the appointment of Frederick M. Lowery as its new Chief Executive Officer ("CEO"), effective March 2, 2026, at which time he will join the Board of Directors. Mr. Lowery succeeds Stanley M. Bergman, who will step down as CEO after 35 years and continue to serve as Chairman of the Board to ensure a smooth and effective leadership transition. This press release features multimedia. View the full release here: https://www.businesswire

    1/12/26 7:00:00 AM ET
    $HSIC
    $TMO
    Medical Specialities
    Health Care
    Industrial Machinery/Components
    Industrials

    Stanley M. Bergman to Retire as Henry Schein's Chief Executive Officer at the End of 2025

    Mr. Bergman to Continue to Serve as Chairman of the Board Henry Schein, Inc. (NASDAQ:HSIC), the world's largest provider of health care solutions to office-based dental and medical practitioners, announced today that Stanley M. Bergman will retire as Chief Executive Officer (CEO) at the end of the year after 45 years at the Company, including more than 35 years as CEO. Mr. Bergman will continue to lead Henry Schein in his current role until his retirement and will remain as Chairman thereafter. The Board is commencing a formal search process in conjunction with a nationally recognized executive search firm and will consider internal and external candidates. "With the progress made advan

    7/15/25 7:05:00 AM ET
    $HSIC
    Medical Specialities
    Health Care